Pyxis Oncology (PYXS) Insider Trading & Ownership $1.55 -0.06 (-3.73%) As of 01/10/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Pyxis Oncology (NASDAQ:PYXS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.80%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$174,146.00Number OfInsiders Selling(Last 12 Months)0 Get PYXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PYXS Insider Buying and Selling by Quarter Pyxis Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/26/2024Pamela Ann ConnealyCFOBuy88,850$1.96$174,146.00 (Data available from 1/1/2013 forward) PYXS Insider Trading Activity - Frequently Asked Questions Who is on Pyxis Oncology's Insider Roster? The list of insiders at Pyxis Oncology includes Jitendra Wadhane, Lara Sullivan, Mark Chin, Pamela Ann Connealy, and Pfizer Inc. Learn more on insiders at PYXS. What percentage of Pyxis Oncology stock is owned by insiders? 9.80% of Pyxis Oncology stock is owned by insiders. Learn more on PYXS's insider holdings. Which Pyxis Oncology insiders have been buying company stock? The following insiders have purchased PYXS shares in the last 24 months: Jitendra Wadhane ($17,875.00), Pamela Ann Connealy ($214,774.10), and Pfizer Inc ($4,999,999.44). How much insider buying is happening at Pyxis Oncology? Insiders have purchased a total of 1,933,870 PYXS shares in the last 24 months for a total of $5,232,648.54 bought. Which Pyxis Oncology insiders have been selling company stock? The following insider sold PYXS shares in the last 24 months: Lara Sullivan ($70,146.10). How much insider selling is happening at Pyxis Oncology? Insiders have sold a total of 31,541 Pyxis Oncology shares in the last 24 months for a total of $70,146.10 sold. Pyxis Oncology Key ExecutivesDr. Lara S. Sullivan M.D.MBA, CEO, President & DirectorMs. Pamela Yanchik Connealy M.B.A. (Age 62)CFO & COO Compensation: $709.7kDr. Ken Kobayashi FACP (Age 63)M.D., Chief Medical Officer Compensation: $314.08kMr. Jitendra Wadhane (Age 43)Chief Accounting Officer, Senior VP of Finance & Corporate Controller Dr. Balu N. Balasubramanian Ph.D.Interim Chief Technology OfficerDr. Jan Pinkas Ph.D.Chief Scientific OfficerDr. Charles T. Gombar Ph.D.Senior Vice President of Portfolio & Program Management More Insider Trading Tools from MarketBeat Related Companies Taysha Gene Therapies Insider Transactions Aura Biosciences Insider Transactions REGENXBIO Insider Transactions ChromaDex Insider Transactions Akebia Therapeutics Insider Transactions Korro Bio Insider Transactions Corvus Pharmaceuticals Insider Transactions Sana Biotechnology Insider Transactions Organogenesis Insider Transactions Sage Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher This page (NASDAQ:PYXS) was last updated on 1/13/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
